CSD210904: Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers
A Multi-Site Study to Assess Actual Use of a Heated Tobacco Product With Four Non-Combusted Cigarette Variants in Current Adult Smokers
1 other identifier
observational
1,180
1 country
10
Brief Summary
This is a multi-site, open-label, 8-week, prospective observational study, conducted at multiple sites geographically dispersed within the U.S. The purpose of this Actual Use Study (AUS) is to investigate how U.S. adult tobacco consumers 21 to 60 years of age, inclusive, who typically smoke on average (≥5 cigarettes/day) on at least 20 out of the past 30 days will use a heated tobacco product comprising a heating device and four non-combusted cigarette variants (HTP Investigational Product \[IP\]) over a 6-week Actual Use Period (AUP) in their real-life/naturalistic environment and in the context of typical consumer marketing materials.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2021
Shorter than P25 for all trials
10 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 20, 2021
CompletedStudy Start
First participant enrolled
October 26, 2021
CompletedFirst Posted
Study publicly available on registry
November 2, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 8, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 8, 2022
CompletedJune 24, 2022
June 1, 2022
4 months
October 20, 2021
June 23, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
Number and Proportion of Established Users
Number and proportion of subjects who meet the definition of "established users" of the HTP IP
6 weeks
Number and Proportion of Established Users who reduce their CPD consumption
Number and proportion of subjects among "established users" of the HTP IP who reduce their CPD consumption by at least 50%
8 weeks
Descriptive weekly average CPD consumption
Descriptive weekly average CPD consumption per subject among all subjects who complete the study, including both established and non-established users of the HTP IP
8 weeks
Interventions
A non-combusted cigarette used with heated tobacco device 20020064
A non-combusted cigarette used with heated tobacco device 20020064
A non-combusted cigarette used with heated tobacco device 20020064
A non-combusted cigarette used with heated tobacco device 20020064
Eligibility Criteria
The study sample will comprise generally healthy, U.S. adult tobacco consumers 21 to 60 years of age, inclusive, who are regular smokers (≥5 cigarettes/day) on at least 20 of 30 days, who are not currently quitting all Tobacco- and/or Nicotine-containing Product (TNP) use, and who have no intention of quitting all TNP use in the next three months (quitting CC use only is allowable). Once enrolled, subjects confirming an intent to quit all TNP use during the AUP will be discontinued. A recruiting target for younger smokers (21-30 years old) of approximately 15% will be established to ensure that they are sufficiently represented among the enrolled subjects.
You may qualify if:
- Adult males or females, 21-60 years old, inclusive, verified with government-issued photo ID.
- Must be a current smoker of factory-made filtered menthol and/or non-menthol cigarettes, has smoked at least 100 cigarettes in their lifetime, and typically smoke on at least 20 days out of the past 30 days.
- Smokes, on average, ≥ 5 combustible cigarettes per day (CPD) on days when cigarettes are smoked.
- Must indicate "an intention to use" the HTP IP after a brief review of product information at the Screening and Enrollment Visit (SEV). Subjects will not try the product at the SEV.
- Available and interested in participating in an 8-week study about the HTP IP.
- Able and willing to comply with all study requirements, including questionnaires, the eDiary reporting procedures, and provide valid contact information.
- Able to read, understand, and willing to sign Informed Consent Forms (ICFs) and complete questionnaires written in English.
- Has not participated in any tobacco-, vapor-, or nicotine-related research within 3 months of screening.
You may not qualify if:
- Self-reports as currently quitting or intending to quit within the next 3 months all tobacco or nicotine product use ("currently" is defined as within (≤) 30 days prior to signing ICF#1). Those who intend to quit CC only can be enrolled.
- Female subjects who are currently pregnant or breastfeeding or planning to become pregnant or start breastfeeding within the next 6 months based on self-report.
- Female subjects who self-report they are not using adequate methods to prevent pregnancy.
- Self-reports "poor" physical health (based on the five-category Population Assessment of Tobacco and Health (PATH) questionnaire): "In general, how would you rate your physical health?" (Response choices: Excellent, Very Good, Good, Fair, Poor).
- Self-reports "poor" mental health (based on the five-category PATH questionnaire): "In general, how would you rate your mental health?" (Response choices: Excellent, Very Good, Good, Fair, Poor).
- Employees of tobacco or vapor companies.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (10)
Schlesinger Atlanta
Atlanta, Georgia, 30328, United States
Schlesinger Chicago
Chicago, Illinois, 60611, United States
Schlesinger Baltimore
Baltimore, Maryland, 21204, United States
Schlesinger Minneapolis
Edina, Minnesota, 55439, United States
Schlesinger Kansas City
Kansas City, Missouri, 64114, United States
Schlesinger St. Louis
St Louis, Missouri, 63131, United States
Schlesinger Charlotte
Charlotte, North Carolina, 28273, United States
Schlesinger Nashville
Nashville, Tennessee, 37203, United States
Schlesinger Dallas
Dallas, Texas, 75254, United States
Schlesinger Houston
Houston, Texas, 77027, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Mandara Shetty
BAT/RAIS
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 20, 2021
First Posted
November 2, 2021
Study Start
October 26, 2021
Primary Completion
March 8, 2022
Study Completion
March 8, 2022
Last Updated
June 24, 2022
Record last verified: 2022-06
Data Sharing
- IPD Sharing
- Will not share